Stroud company gets green light for pain relief product

A Stroud medical equipment company has been given special accreditation to produce and market a pain relief device in Britain and Europe.

After nearly four years of investigation into the claims of the device, Platform 14 has just been given neuro modulation certification for its BiowaveGo product.

And the founder of Platform 14, Steve Dechan, 52 has now taken a 12 per cent stake in the Biowave Group in the United States, which has been producing the pocket-sized device for the American market for the last 14 years,

Platform14 is now expanding its Stroud operation to manufacture and assemble the devices, which are on sale through Amazon and their website for £385.

By the end of this year, Platform 14 aims to employ 25 local people from the Stroud area at its new Griffin Mill manufacturing and distribution centre.

The BioWaveGo device is already being used by several premiership soccer clubs and horse racing trainers to cope with pain.

And Platform 14 has also become one of the ground sponsors at Rangers in Glasgow where players have also been using the device.

“We are actively helping elite sports people with their pain issues”, said Steve Dechan, 52, who is an ultra-marathon runner himself.

“BioWaveGo is able to help these elite sports people through pain as they are unable to take certain drugs. In America, we have had great success with the pain treatment of NFL and ice hockey players.”

Steve Dechan said the key component of BioWaveGo is to transmit high frequency electric signals to relieve pain-blocking the signal at the nerve to deliver relief without the need for opioid drugs.

“Our aim is to remove chronic pain for thousands of people without the use of drugs”, he added.

The World Institute of Pain’s president-elect, Dr Dominic Hegarty, has joined the board of Platform14 to help the introduction of BioWaveGo to the UK and European market.

Dr Hegarty said: ”For the millions of people that experience  pain that prevents them from everyday tasks such as shopping, driving their cars or walking the dog, having the ability to provide an effective, reliable and affordable pain therapy is fundamental in the personalisation of pain management”

It has taken two and a half years for Platform 14 to convince the British and European regulators that the pain relief claims of BioWaveGo are medically substantiated.

Platform 14 was set up as a medical equipment supply company nine years ago in Stroud.

And since the start of the Covid pandemic, the company has supplied £300 million of PPE to the NHS and is now also supplying lateral flow and saliva tests.

“One of the frequent questions I am asked”, said Steve Dechan,”Is have we used the Covid PPE business to expand our company into BioWave.

“The answer is yes – absolutely. Having said that our ethos is that we did not profit hugely for the supplies to the NHS. They were supplied on very low margins.

“We were a medical company before the pandemic, unlike many others who supplied PPE to the government.

“And we are still a medical company supplying the NHS.”